Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1321896

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1321896

Global Diabetes Care Devices Market Size, Share, Growth Analysis, By Product(Blood glucose monitoring devices), By End-use - Industry Forecast 2023-2030

PUBLISHED:
PAGES: 157 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Diabetes Care Devices Market size was valued at USD 26.7 billion in 2021 and is poised to grow from USD 29.02 billion in 2022 to USD 56.57 billion by 2030, growing at a CAGR of 8.7% in the forecast period (2023-2030).

The global diabetes care devices market is witnessing significant growth due to the rising prevalence of diabetes worldwide. These devices help in managing and monitoring blood glucose levels, improving patient outcomes. Factors such as technological advancements, increasing awareness about diabetes management, and the growing geriatric population are driving market growth. The market is expected to continue expanding in the coming years, driven by the increasing demand for minimally invasive and portable devices for diabetes care.

Top-down and bottom-up approaches were used to estimate and validate the size of Diabetes Care Devices and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report:

Diabetes Care Devices Market is segmented on the basis of product type, end user, and region. By product, the Diabetes Care Devices Market segment is divided into blood glucose monitoring devices and insulin delivery devices. Blood glucose segment is further segmented into self-monitoring blood glucose meters, continuous glucose monitors, testing strips, and lancets. Insulin delivery devices are further segmented into insulin pumps (tubed pumps and tubeless pumps), pens (reusable and disposable), pen needles (standard and safety), syringes, and others. By end use, the market is segmented into hospitals, ambulatory surgery centers, diagnostic centers, home care, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and MEA.

Driver

The market is experiencing growth due to the increasing use of insulin-delivery devices and the growing prevalence of diabetes. Sedentary lifestyles and unhealthy choices have resulted in a rising number of Type-2 diabetes diagnoses. According to the International Diabetes Federation (IDF), approximately 537 million adults worldwide have diabetes, which can lead to the development of various chronic diseases. Consequently, there is a significant need to effectively manage and control diabetes.

Restrain

the global diabetes care devices market may encounter obstacles during the forecast period. Limited access to these devices in underdeveloped regions and challenges related to registration processes and reimbursement issues are expected to restrict market growth.

Trend

The growth of the diabetes monitoring devices segment is primarily driven by the increased adoption of test strips, self-monitoring blood glucose meters, and the growing demand for continuous glucose monitoring. Developing countries are witnessing a rise in awareness about the disease, contributing to this trend. The World Health Organization (WHO) reports that over 60% of the global population lacks sufficient physical activity. Active employment is considered vital for maintaining a healthy lifestyle, and the risk of developing type 2 diabetes increases with higher body weight across all age groups. As individuals become more health-conscious, the global market offers lucrative growth opportunities for industry players.

Product Code: SQSG35B2039

Table of Contents

  • Executive Summary
    • Market Overview
    • Wheel of Fortune
  • Research Methodology
    • Information Procurement
    • Secondary & Primary Data Sources
    • Market Size Estimation
    • Market Assumptions & Limitations
  • Parent Market Analysis
    • Market Overview
    • Market Size
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Key Market Insights
    • Technology Analysis
    • Pricing Analysis
    • Supply Chain Analysis
    • Value Chain Analysis
    • Ecosystem of the Market
    • IP Analysis
    • Trade Analysis
    • Startup Analysis
    • Raw Material Analysis
    • Innovation Matrix
    • Pipeline Product Analysis
    • Macroeconomic Indicators
    • Top Investment Analysis
    • Key Success Factor
    • Degree of Competition
  • Market Dynamics & Outlook
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
    • Regulatory Landscape
    • Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
    • Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Diabetes Care Devices Market by Product
    • Market Overview
    • Blood glucose monitoring devices (Self-monitoring blood glucose meters
    • continuous glucose monitors
    • testing strips
    • lancets)
    • Insulin Delivery Devices (Insulin delivery devices {insulin pumps-tubed pumps
    • tubeless pumps}
    • pens{reusable
    • disposable}
    • pen needles {standard
    • safety}
    • syringes
    • others)
  • Global Diabetes Care Devices Market by End-use
    • Market Overview
    • Hospitals
    • ambulatory surgery centres
    • diagnostic centres
    • home care
    • clinics
    • others
  • Global Diabetes Care Devices Market Size by Region
    • Market Overview
    • North America
  • USA
  • Canada
    • Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
    • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
    • Latin America
  • Brazil
  • Rest of Latin America
    • Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA
  • Competitive Landscape
    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2021
    • Strategies Adopted by Key Market Players
    • Top Winning Strategies
  • By Development
  • By Company
  • By Year
    • Recent Activities in the Market
    • Key Companies Market Share (%), 2021
  • Key Company Profiles
    • Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Ascensia Diabetes Care
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Dexcom, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Eli Lilly and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • F. Hoffmann-La Roche AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Insulet Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Nova Biomedical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Novo Nordisk A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Omron Healthcare, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Sanofi S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Tandem Diabetes Care, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Trividia Health, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Ypsomed AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • ARKRAY Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Glooko, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • GlySens Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!